Vitamin C and zinc play important roles in nutrition, immune defence and maintenance of health. Intake of both is often inadequate, even in affluent populations. The common cold continues to place a great burden on society in terms of suffering and economic loss. After an overview of the literature on the effects of the separate administration of either vitamin C or zinc against the common cold, this article presents data from two preliminary, double-blind, randomized, placebo-controlled trials, conducted with a combination of 1000 mg vitamin C plus 10 mg zinc in patients with the common cold. In both studies, a nonsignificant reduction of rhinorrhoea duration (range 9 – 27%) was seen. In pooled analyses of both studies (n = 94), vitamin C plus zinc was significantly more efficient than placebo at reducing rhinorrhoea over 5 days of treatment. Furthermore, symptom relief was quicker and the product was well tolerated. In view of the burden associated with the common cold, supplementation with vitamin C plus zinc may represent an efficacious measure, with a good safety profile, against this infectious viral disease.
CarrACFreiB: Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr1999; 69: 1086–1107.
2.
MagginiSWenzlaffSHornigD: Essential role of vitamin C and zinc in child immunity and health. J Int Med Res2010; 38: 386–414.
3.
WintergerstESMagginiSHornigDH: Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab2006; 50: 85–94.
4.
StefanidouMMaraveliasCDonaA: Zinc: A multipurpose trace element. Arch Toxicol2006; 80: 1–9.
5.
PlumLMRinkLHaaseH: The essential toxin: impact of zinc on human health. Int J Environ Res Public Health2010; 7: 1342–1365.
6.
FieldCJJohnsonIRSchleyPD: Nutrients and their role in host resistance to infection. J Leukoc Biol2002; 71: 16–32.
AndersonRSmitMJJooneGKVitamin C and cellular immune functions. Protection against hypochlorous acid-mediated inactivation of glyceraldehyde-3-phosphate dehydrogenase and ATP generation in human leukocytes as a possible mechanism of ascorbate-mediated immunostimulation. Ann N Y Acad Sci1990; 587: 34–48.
9.
BhaskaramP: Micronutrient malnutrition, infection, and immunity: an overview. Nutr Rev2002; 60: S40–S45.
10.
PanushRSDelafuenteJCKatzP: Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses. Int J Vitam Nutr Res Suppl1982; 23: 35–47.
11.
StröhleAHahnA: Vitamin C and immune function. Med Monatsschr Pharm2009; 32: 49–54 [in German, English abstract].
12.
KennesBDumontIBroheeDEffect of vitamin C supplements on cell-mediated immunity in old people. Gerontology1983; 29: 305–310.
13.
KeenCLGershwinME: Zinc deficiency and immune function. Annu Rev Nutr1990; 10: 415–431.
14.
SalgueiroMJZubillagaMLysionekA: Zinc status and immune system relationship: A review. Biol Trace Elem Res2000; 76: 193–205.
15.
TapieroHTewKD: Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother2003; 57: 399–411.
16.
DardenneMBachJ-F: Rationale for the mechanism of zinc interaction in the immune system. In: Nutrient Modulation of the Immune Response (Cunningham-RundlesS ed). New York: Marcel Dekker Inc., 1993; pp 501–509.
17.
PrasadAS: Zinc: an overview. Nutrition1995; 11 (1 suppl): 93–99.
18.
KnightJA: Review: Free radicals, antioxidants, and the immune system. Ann Clin Lab Sci2000; 30: 145–158.
19.
MeydaniSNWuDSantosMS: Antioxidants and immune response in aged persons: overview of present evidence. Am J Clin Nutr1995; 62 (6 suppl): 1462S–1476S.
20.
DeruelleFBaronB: Vitamin C: is supplementation necessary for optimal health?J Altern Complement Med2008; 14: 1291–1298.
21.
HemiläHDouglasRM: Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis1999; 3: 756–761.
22.
StröhleAWoltersMHahnA: Micronutrients at the interface between inflammation and infection ascorbic acid and calciferol. Part 1: general overview with a focus on ascorbic acid. Inflamm Allergy Drug Targets2011; 10: 54–63.
23.
FabrisNMocchegianiE: Zinc, human diseases and aging. Aging (Milano)1995; 7: 77–93.
24.
FendrickAMMontoASNightengaleB: The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med2003; 163: 487–494.
25.
HeikkinenTJärvinenA: The common cold. Lancet2003; 361: 51–59.
26.
SinghMDasRR: Zinc for the common cold. Cochrane Database Syst Rev2011; 2: CD001364.
27.
LorberB: The common cold. J Gen Intern Med1996; 11: 229–236.
KallnerABHartmannDHornigDH: On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr1981; 34: 1347–1355.
30.
HuttunenRHeikkinenTSyrjänenJ: Smoking and the outcome of infection. J Intern Med2011; 269: 258–269.
31.
NuortiJPButlerJCFarleyMM: Cigarette smoking and invasive pneumococcal disease. N Engl J Med2000; 342: 681–689.
32.
ShahSASanderSWhiteCM: Evaluation of echinacea for the prevention and treatment of the common cold: A meta-analysis. Lancet Infect Dis2007; 7: 473–480.
33.
De VecchiEDragoL: Propolis’ antimicrobial activity: what's new?Infez Med2007; 15: 7–15 [in Italian, English abstract].
34.
McElhaneyJEGoelVToaneB: Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: A randomized, double-blinded, placebo controlled trial. J Altern Complement Med2006; 12: 153–157.
35.
ScaglioneFCattaneoGAlessandriaM: Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res1996; 22: 65–72.
36.
TalbottSTalbottJ: Effect of beta 1,3/1,6 glucan on upper respiratory tract infection symptoms and mood state in marathon athletes. J Sports Sci Med2009; 8: 509–515.
37.
TalbottSTalbottJ: Beta 1,3/1,6 glucan decreases upper respiratory tract infection symptoms and improves psychological well-being in moderate to highly-stressed subjects. Agro Food Industry Hi-Tech2010; 21: 21–24.
38.
MeydaniSNHanSNWuD: Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev2005; 205: 269–284.
39.
AndersonTWBeatonGHCoreyP: Winter illness and vitamin C: the effect of relatively low doses. Can Med Assoc J1975; 112: 823–826.
40.
JaffeGM: Vitamin C. New York: Marcel Dekker, 1984; pp 199–244.
41.
HumeRWeyersE: Changes in leucocyte ascorbic acid during the common cold. Scott Med J1973; 18: 3–7.
42.
ChalmersTC: Effects of ascorbic acid on the common cold. An evaluation of the evidence. Am J Med1975; 58: 532–536.
43.
HemiläHHermanZS: Vitamin C and the common cold: A retrospective analysis of Chalmers’ review. J Am Coll Nutr1995; 14: 116–123.
44.
HemiläH: Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition1996; 12: 804–809.
45.
HemiläH: Does vitamin C alleviate the symptoms of the common cold? A review of current evidence. Scand J Infect Dis1994; 26: 1–6.
46.
HemiläH: Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit. Med Hypotheses1999; 52: 171–178.
47.
DouglasRMHemiläHChalkerE: Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev2007; 3: CD000980.
48.
GortonHCJarvisK: The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manipulative Physiol Ther1999; 22: 530–533.
49.
AndersonTWSuranyiGBeatonGH: The effect on winter illness of large doses of vitamin C. Can Med Assoc J1974; 111: 31–36.
50.
HeimerKAHartAMMartinLG: Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold. J Am Acad Nurse Pract2009; 21: 295–300.
51.
KorantBDKauerJCButterworthBE: Zinc ions inhibit replication of rhinoviruses. Nature1974; 248: 588–590.
52.
JacksonJLLeshoEPetersonC: Zinc and the common cold: A meta-analysis revisited. J Nutr2000; 130 (5S suppl): 1512S–1515S.
53.
MarshallI: Zinc for the common cold. Cochrane Database Syst Rev2000; 2: CD001364.
54.
HemiläH: Zinc lozenges may shorten the duration of colds: A systematic review. Open Respir Med J2011; 5: 51–58.
55.
KurugölZAkilliMBayramN: The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatr2006; 95: 1175–1181.
56.
VakiliRVahedianMKhodaeiG: Effects of zinc supplementation in occurrence and duration of common cold in school aged children during cold season: A double-blind placebo-controlled trial. Iran J Pediatr2009; 19: 376–380.
57.
TurnerRBCetnarowskiWE: Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis2000; 31: 1202–1208.
58.
EFSA (European Food Safety Authority): Tolerable Upper Intake Levels for Vitamins and Minerals. Scientific Committee on Food and Scientific Panel on Dietetic Products, Nutrition and Allergies2006Parma: EFSA (available at: http://www.efsa.europa.eu/en/ndatopics/docs/ndatolerableuil.pdf).
59.
Institute of Medicine: Vitamin C. In: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids: A Report of the Panel on Micronutrients, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academic Press, 2000; pp 95–185.
60.
Institute of Medicine: Zinc. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc: A Report of the Panel on Micronutrients, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academy Press, 2001; pp 442–501.
61.
MagginiS: Vitamins and minerals: contribution to immune function and health. In: Dietary Components and Immune Function (WatsonRRZibadiSPreedyVR eds). New York: Springer Science+Business Media LLC, 2010; pp 227–252.
62.
World Health Organization (WHO): The Global Burden of Disease. 2004 Update. Geneva: WHO, 2008.
63.
KhannaMKumarPChoudharyKEmerging influenza virus: A global threat. J Biosci2008; 33: 475–482.
64.
MainesTRSzretterKJPerroneL: Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev2008; 225: 68–84.
65.
KuikenTTaubenbergerJK: Pathology of human influenza revisited. Vaccine2008; 26 (suppl 4): D59–D66.
66.
MichaelisMDoerrHWCinatlJJr: Of chickens and men: avian influenza in humans. Curr Mol Med2009; 9: 131–151.
67.
PappaioanouM: Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?Comp Immunol Microbiol Infect Dis2009; 32: 287–300.
68.
ChowellGBertozziSMColcheroMA: Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med2009; 361: 674–679.
69.
Perez-PadillaRde la Rosa-ZamboniDde LeonS Ponce: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med2009; 361: 680–689.
70.
DesselbergerU: Emerging and re-emerging infectious diseases. J Infect2000; 40: 3–15.
71.
DaszakPCunninghamAAHyattAD: Emerging infectious diseases of wildlife—threats to biodiversity and human health. Science2000; 287: 443–449.
72.
BinderSLevittAMSacksJJ: Emerging infectious diseases: public health issues for the 21st century. Science1999; 284: 1311–1313.
73.
AlbersRAntoineJMSicardR Bourdet: Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr2005; 94: 452–481.
74.
DelvesPJRoittIM: The immune system. Second of two parts. N Engl J Med2000; 343: 108–117.
75.
DelvesPJRoittIM: The immune system. First of two parts. N Engl J Med2000; 343: 37–49.
76.
ParkinJCohenB: An overview of the immune system. Lancet2001; 357: 1777–1789.
